GLP-1 drugs are changing the way we treat obesity.
But a new multinational report says if you rely on the shot alone, you’re leaving a lot of health — and money — on the table.
What the report shows
A new white paper, From Weight Loss to Lasting Value: Structured Exercise and the Economics of GLP-1 Therapy, looked at what happens when you pair GLP-1 medications with regular, structured exercise instead of using the drugs on their own.
Health economists modeled two paths across five countries — the U.S., U.K., Canada, Australia, and New Zealand:
- GLP-1 therapy alone
- GLP-1 therapy plus structured exercise, including strength training
They weren’t just counting pounds lost. They looked at long‑term health outcomes, avoided medical events, healthcare costs, and wider economic value over 10‑ and 30‑year time frames.
Across all five countries, the same pattern showed up: adding exercise to GLP-1 therapy improves health and produces a positive economic return. Medication alone simply doesn’t deliver the same long‑term value.
The money numbers are huge.
The report puts actual price tags on the combo approach.
Over 10 years, structured exercise alongside GLP‑1 use is estimated to generate roughly:
- United States: about US$120 billion in economic and societal value and a 496% return on investment
- Australia: about A$182 million and a 59% return
- Canada: about C$3.5 billion and a 105% return
- New Zealand: about NZ$51 million and a 27% return
- United Kingdom: about £2.7 billion and a 164% return
Stretch that out to 30 years, and the numbers explode:
- United States: around US$393 billion in value and a 1,572% return
- Australia: around A$1.4 billion and a 457% return
- Canada: around C$17.9 billion and a 526% return
- New Zealand: around NZ$592 million and a 306% return
- United Kingdom: around £13 billion and a 717% return
The message is blunt: combining GLP‑1s with exercise isn’t a “nice extra,” it’s an economic no‑brainer.
Why exercise matters so much with GLP‑1s
The report isn’t just about budgets. It lays out why moving your body changes what these drugs can do for you over time.
Compared with medication alone, adding structured exercise can help people:
- Preserve muscle mass while the scale goes down.
- Maintain strength, mobility, and bone health.
- Keep more weight off over the long term.
- Reduce weight regain after stopping the drug.
- Lower the risk of expensive health events later.
In the U.S. alone, the modeling suggests that pairing GLP‑1 therapy with structured exercise over 10 years could help avoid roughly 48,000 acute cardiovascular events and 160,000 joint replacements. That’s fewer heart attacks, fewer blown‑out knees and hips, and fewer people cycling back into major surgery after “successful” weight loss.
Think of GLP‑1s as taking your foot off the gas.
Exercise is what keeps the engine strong and the car on the road.
Why the fitness world is getting loud about this
On the back of this report, major fitness and industry groups — including the Health & Fitness Association, the HFA Foundation, AUSactive, Exercise New Zealand, the Fitness Industry Council of Canada, and UKactive — are pushing policymakers and payers to bake exercise into GLP‑1 care from the start.
Their wish list is pretty straightforward:
- Treat structured exercise, including strength training, as essential obesity care, not an optional hobby.
- Build exercise support directly into GLP‑1 treatment models.
- Create referral pathways from clinics to qualified trainers and fitness facilities.
- Help patients actually access those professionals and places.
- Track outcomes beyond weight — strength, function, health events, economic value
This builds on a recent joint position statement with the World Obesity Federation and others, all saying the same thing: as obesity meds roll out globally, physical activity and nutrition can’t be bolted on as an afterthought. They have to be part of the system.
What this means if you’re on (or considering) a GLP‑1
If you’re using a GLP‑1 or considering it, this report is a roadmap for getting more from a very expensive tool.
In real life, that looks like:
- Don’t wait to “finish losing” before you start moving. The muscle you save now is the strength you’ll still have later.
- Make strength training non‑negotiable a couple of times a week. You’re not training for a bodybuilding show; you’re protecting muscle, bones, and joints.
- Add regular cardio (walking, cycling, swimming, whatever you’ll actually do) to support heart health and conditioning.
- Ask your prescriber what support exists — referrals to exercise professionals, discounted or covered programs, structured plans — and push for more than “just take the shot.”
Obesity drugs can help people lose a lot of weight. Exercise is what helps that weight loss translate into lasting health rather than a temporary number on the scale.
Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always speak with a qualified health care provider prior to starting or changing any medication, diet, or exercise program, especially if you have chronic health conditions, mobility issues, or concerns about how to safely combine GLP‑1 therapy with physical activity.
